Edoardo Missiaglia

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


94 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
Sous presse
 
Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology.
Christinat Y., Hamelin B., Alborelli I., Angelino P., Barbié V., Bisig B., Dawson H., Frattini M., Grob T., Jochum W. et al. Virchows Archiv. Peer-reviewed.
[DOI][Pmid][serval:BIB_9449E5D83468]
 
Deep phenotyping of nodal T-cell lymphomas reveals immune alterations and therapeutic targets.
Stephan P., Perrot J., Voisin A., Barbery M., Andrieu T., Grimont M., Caramel J., Bardou M., Tondeur G., Missiaglia E. et al. Haematologica. Peer-reviewed.
[DOI][Pmid][serval:BIB_024B39589E43]
2024
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.
Fischer A., Albert T.K., Moreno N., Interlandi M., Mormann J., Glaser S., Patil P., de Faria F.W., Richter M., Verma A. et al., 2024/10/03. Nature communications, 15 (1) p. 8571. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_90C14EE77C2E]
 
Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R., Bisig B., Guey B., Missiaglia E., Cairoli A., Omoumi P., Letovanec I., Ferry J.A., Hasserjian R.P., de Leval L., 2024/04. Modern pathology, 37 (4) p. 100440. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8D5FC967934E]
2023
 
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.
Bobisse S., Bianchi V., Tanyi J.L., Sarivalasis A., Missiaglia E., Pétremand R., Benedetti F., Torigian D.A., Genolet R., Barras D. et al., 2023/10. Nature cancer, 4 (10) pp. 1410-1417. Peer-reviewed.
[DOI][Pmid][serval:BIB_E6692BB52E6C]
 
POSTER: TCL-330 RHOA G17V Potentiates CD28-Induced NFAT Transcriptional Activity by Modulating p300 Activity: A Step Further in the Understanding of Follicular Helper T-Cell Lymphoma
Vallois David, Juilland Mélanie, Kalliopi Ioannidou, Lemmonier François, Missiaglia Edoardo, Bisig Bettina, Thome Margot, de Leval Laurence, 2023/09. pp. S214 dans Clinical Lymphoma Myeloma and Leukemia, Elsevier BV.
[DOI][serval:BIB_B00CB4F58EB3]
 
Lack of smarcb1 expression characterizes a subset of peripheral t‐cell lymphomas enriched in children and young adults.
Fischer A., Moreno N., Interlandi M., Albert T. K., Mormann J., Glaser S., Patil P., Balbach S., Wagener R., Bens S. et al., 2023/06. pp. 192-192 dans Hematological Oncology, Wiley.
[DOI][serval:BIB_7CBB22D1E10A]
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma.
Krebs F.S., Moura B., Missiaglia E., Aedo-Lopez V., Michielin O., Tsantoulis P., Bisig B., Trimech M., Zoete V., Homicsko K., 2023/02/24. International journal of molecular sciences, 24 (5) p. 4520. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E3A48A3138B7]
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
Veloza L., Cavalieri D., Missiaglia E., Ledoux-Pilon A., Bisig B., Pereira B., Bonnet C., Poullot E., Quintanilla-Martinez L., Dubois R. et al., 2023/01/01. Haematologica, 108 (1) pp. 181-195. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_263F9CD467CA]
2022
 
Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
Bisig B., Cairoli A., Gaide O., Somja J., Bregnard C., Gaulard P., Xerri L., Lefort K., Missiaglia E., Gilliet M. et al., 2022/10. Virchows Archiv, 481 (4) pp. 653-657. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CF9902CA42C]
 
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
Nicolae A., Bouilly J., Lara D., Fataccioli V., Lemonnier F., Drieux F., Parrens M., Robe C., Poullot E., Bisig B. et al., 2022/08. Modern pathology, 35 (8) pp. 1126-1136. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F6CBED5D1F0D]
FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas.
Milton C.I., Selfe J., Aladowicz E., Man SYK, Bernauer C., Missiaglia E., Walters Z.S., Gatz S.A., Kelsey A., Generali M. et al., 2022/03. Molecular oncology, 16 (6) pp. 1272-1289. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6F675513FACC]
2021
CD73 expression in normal, hyperplastic, and neoplastic thyroid: a systematic evaluation revealing CD73 overexpression as a feature of papillary carcinomas.
Monteiro I., Missiaglia E., Sciarra A., Santos J.V., Bouilly J., Romero P., Sempoux C., de Leval L., 2021/07. Virchows Archiv, 479 (1) pp. 209-214. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DCA4A5411D48]
 
Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
Trimech M., Letourneau A., Missiaglia E., De Prijck B., Nagy-Hulliger M., Somja J., Vivario M., Gaulard P., Lambert F., Bisig B. et al., 2021/06/01. The American journal of surgical pathology, 45 (6) pp. 773-786. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC97D082A0AB]
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
Lemonnier F., Safar V., Beldi-Ferchiou A., Cottereau A.S., Bachy E., Cartron G., Fataccioli V., Pelletier L., Robe C., Letourneau A. et al., 2021/01/26. Blood advances, 5 (2) pp. 539-548. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB2690885CDD]
2020
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma in Asia Frequently Shows SETD2 Alterations.
Tomita S., Kikuti Y.Y., Carreras J., Sakai R., Takata K., Yoshino T., Bea S., Campo E., Missiaglia E., Bouilly J. et al., 2020/11/27. Cancers, 12 (12) p. 3539. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_86378DB83C45]
Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology.
Krebs F.S., Gérard C., Wicky A., Aedo-Lopez V., Missiaglia E., Bisig B., Trimech M., Michielin O., Homicsko K., Zoete V., 2020/10/28. International journal of molecular sciences, 21 (21) pp. E8021. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_44F221AEB60A]
Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the Literature.
Sciarra A., Missiaglia E., Trimech M., Melloul E., Brouland J.P., Sempoux C., La Rosa S., 2020/03. Endocrine pathology, 31 (1) pp. 84-93. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5D5156403DAC]
 
Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma.
Bongiovanni M., Sykiotis G.P., La Rosa S., Bisig B., Trimech M., Missiaglia E., Gremaud M., Salvatori Chappuis V., De Vito C., Sciarra A. et al., 2020/01. Thyroid, 30 (1) pp. 72-80. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3593CD8A9C4E]
2019
Acinar cell carcinoma of the pancreas with thyroid-like follicular features: first description of a new diagnostic challenging subtype.
Saglietti C., Schneider V., Bongiovanni M., Missiaglia E., Bisig B., Dorta G., Demartines N., Sempoux C., La Rosa S., 2019/12. Virchows Archiv, 475 (6) pp. 789-794. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4D0E1AAA380]
 
Deep Response to Anti-PD-1 Therapy of Metastatic Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor With CD274/PD-L1 Amplification.
Özdemir B.C., Bohanes P., Bisig B., Missiaglia E., Tsantoulis P., Coukos G., Montemurro M., Homicsko K., Michielin O., 2019/12. JCO precision oncology, 3 pp. 1-6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E12437A0DD54]
 
The Romand Network of Oncology: bridging the gap of personalised oncology
Michielin O., Tsantoulis P., Homicsko K., Christinat Y., De Leval L., Bisig B., Missiaglia E., Zoete V., Krebs F., Fortin A. et al., 2019/10/18. Swiss Medical Weekly.
[serval:BIB_2A3947B3BCE2]
VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle.
Figeac N., Mohamed A.D., Sun C., Schönfelder M., Matallanas D., Garcia-Munoz A., Missiaglia E., Collie-Duguid E., De Mello V., Pobbati A.V. et al., 2019/07/05. Journal of cell science, 132 (13). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_65F77A5F1F41]
 
MedCo: Enabling Secure and Privacy-Preserving Exploration of Distributed Clinical and Genomic Data
Raisaro Jean Louis, Troncoso-Pastoriza Juan Ramon, Misbach Mickael, Sousa Joao Sa, Pradervand Sylvain, Missiaglia Edoardo, Michielin Olivier, Ford Bryan, Hubaux Jean-Pierre, 2019/07/01. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 16 (4) pp. 1328-1341. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EB26A9E809D5]
 
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Heavican T.B., Bouska A., Yu J., Lone W., Amador C., Gong Q., Zhang W., Li Y., Dave B.J., Nairismägi M.L. et al., 2019/04/11. Blood, 133 (15) pp. 1664-1676. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_61A356E54251]
2018
 
Lenalidomide in Combination with CHOP in Patients with Angioimmunoblastic T-Cell Lymphoma (AITL): Final Analysis of Clinical and Molecular Data of a Phase 2 Lysa Study
Lemonnier Francois, Safar Violaine, de Leval Laurence, Cottereau Anne Ségolène, Pelletier Laura, Robe Cyrielle, Bachy Emmanuel, Cartron Guillaume, Moles Marie-Pierre, Letourneau Audrey et al., 2018/11/29. Blood, 132 (Supplement 1) pp. 999-999.
[DOI][WoS][serval:BIB_B564F69FD41D]
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.
Letourneau A., Maerevoet M., Milowich D., Dewind R., Bisig B., Missiaglia E., de Leval L., 2018/10. Virchows Archiv, 473 (4) pp. 505-511. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CBA7C4E7F28]
RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.
Vallois D., Dupuy A., Lemonnier F., Allen G., Missiaglia E., Fataccioli V., Ortonne N., Clavert A., Delarue R., Rousselet M.C. et al., 2018/08. Haematologica, 103 (8) pp. e360-e363. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FC43A0A259F5]
Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".
Voruz S., Martins F., Cairoli A., Naveiras O., Homicsko K., Missiaglia E., de Leval L., Bisig B., Michielin O., Blum S., 2018/03. Haematologica, 103 (3) pp. e130. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0845E1BF99E5]
Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.
Voruz S., Cairoli A., Naveiras O., de Leval L., Missiaglia E., Homicsko K., Michielin O., Blum S., 2018/01. Haematologica, 103 (1) pp. e39-e41. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_12A8F7D8B626]
2017
 
P13: Breast implant-associated anaplastic large-cell lymphoma presenting as a tumor mass and recurring as a seroma, with dual JAK1 and STAT3 mutations
Bisig B., Letourneau A., Maerevoet M., Millowich D., Dewind R., Missiaglia E., de Leval L., 2017/10/20. p. 578 dans Swiss Pathology Days, Der Pathologe.
[serval:BIB_957A4B6ACCB5]
 
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
Malapelle U., Mayo-de-Las-Casas C., Molina-Vila M.A., Rosell R., Savic S., Bihl M., Bubendorf L., Salto-Tellez M., de Biase D., Tallini G. et al., 2017/08. Cancer, 125 (8) pp. 615-626. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1A52D8AD840C]
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.
Dobay M.P., Lemonnier F., Missiaglia E., Bastard C., Vallois D., Jais J.P., Scourzic L., Dupuy A., Fataccioli V., Pujals A. et al., 2017/04. Haematologica, 102 (4) pp. e148-e151. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_55B41E65EEB9]
 
MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas.
Missiaglia E., Shepherd C.J., Aladowicz E., Olmos D., Selfe J., Pierron G., Delattre O., Walters Z., Shipley J., 2017/01/28. Cancer letters, 385 pp. 251-260. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C87A4FABF4B1]
 
BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression.
Barras D., Missiaglia E., Wirapati P., Sieber O.M., Jorissen R.N., Love C., Molloy P.L., Jones I.T., McLaughlin S., Gibbs P. et al., 2017/01/01. Clinical cancer research, 23 (1) pp. 104-115. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_38D193B4AD19]
2016
 
Epigenetic modulation in well differentiated (WD) and dedifferentiated (DD) liposarcoma (LPS): a novel therapeutic approach
Constantinidou A., Selfe J., Khin T., Popov S., Missiaglia E., Aladowicz E., Al-Saadi R., Olmos D., Jones R.L., Strauss D.C. et al., 2016/10. Annals of Oncology, 27 pp. vi484.
[DOI][serval:BIB_FE7A93D4732B]
The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
Mohamed A., Sun C., De Mello V., Selfe J., Missiaglia E., Shipley J., Murray G.I., Zammit P.S., Wackerhage H., 2016/09. The Journal of pathology, 240 (1) pp. 3-14. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C994B7D261BE]
 
A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
Schell M.J., Yang M., Missiaglia E., Delorenzi M., Soneson C., Yue B., Nebozhyn M.V., Loboda A., Bloom G., Yeatman T.J., 2016. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research, 22 (3) pp. 734-745. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EA19DDA38B3B]
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois D., Dobay M.P., Morin R.D., Lemonnier F., Missiaglia E., Juilland M., Iwaszkiewicz J., Fataccioli V., Bisig B., Roberti A. et al., 2016. Blood, 128 (11) pp. 1490-1502. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A7AD3DD77F83]
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.
Roberti A., Dobay M.P., Bisig B., Vallois D., Boéchat C., Lanitis E., Bouchindhomme B., Parrens M.C., Bossard C., Quintanilla-Martinez L. et al., 2016. Nature Communications, 7 p. 12602. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C7743642D37E]
2015
 
Cerebriforms cells in cerebrum: an unusual finding
Sarro R., Gaide O., Letourneau A., Missiaglia E., Bisig B., Hottinger A., Cairoli A., de Leval L., 2015. p. 633 dans 81. Jahrestagung der Schweizerischen Gesellschaft für Pathologie, Der Pathologe.
[DOI][serval:BIB_D23B3416D5B0]
 
Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.
Hingorani P., Missiaglia E., Shipley J., Anderson J.R., Triche T.J., Delorenzi M., Gastier-Foster J., Wing M., Hawkins D.S., Skapek S.X., 2015. Clinical Cancer Research, 21 (20) pp. 4733-4739. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F32C8231A153]
The consensus molecular subtypes of colorectal cancer.
Guinney J., Dienstmann R., Wang X., de Reyniès A., Schlicker A., Soneson C., Marisa L., Roepman P., Nyamundanda G., Angelino P. et al., 2015. Nature Medicine, 21 (11) pp. 1350-1356. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6206DC2BFE0E]
2014
Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.
Bossard C., Dobay M.P., Parrens M., Lamant L., Missiaglia E., Haioun C., Martin A., Fabiani B., Delarue R., Tournilhac O. et al., 2014/11/06. Blood, 124 (19) pp. 2983-2986. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DB6A51490542]
 
Colorectal Cancer Subtyping Consortium (CRCSC) Identifies Consensus of Molecular Subtypes
Dienstmann R., Guinney J., Delorenzi M., De Reynies A., Roepman P., Sadanandam A., Vermeulen L., Schlicker A., Missiaglia E., Soneson C. et al., 2014/06. Annals of Oncology, 25 pp. ii115.
[DOI][serval:BIB_BAC0004D5B4F]
 
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.
Missiaglia E., Jacobs B., D'Ario G., Di Narzo A.F., Soneson C., Budinska E., Popovici V., Vecchione L., Gerster S., Yan P. et al., 2014. Annals of Oncology, 25 (10) pp. 1995-2001. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_831CA691D120]
JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
Walters Z.S., Villarejo-Balcells B., Olmos D., Buist T.W., Missiaglia E., Allen R., Al-Lazikani B., Garrett M.D., Blagg J., Shipley J., 2014. Oncogene, 33 (9) pp. 1148-1157. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DA4FFBE68A20]
 
The Hippo Transducer YAP1 Transforms Activated Satellite Cells and Is a Potent Effector of Embryonal Rhabdomyosarcoma Formation.
Tremblay A.M., Missiaglia E., Galli G.G., Hettmer S., Urcia R., Carrara M., Judson R.N., Thway K., Nadal G., Selfe J.L. et al., 2014. Cancer Cell, 26 (2) pp. 273-287. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75869B0B427E]
2013
Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments.
Ehnman M., Missiaglia E., Folestad E., Selfe J., Strell C., Thway K., Brodin B., Pietras K., Shipley J., Östman A. et al., 2013/04/01. Cancer research, 73 (7) pp. 2139-2149. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_946C8AB8E80F]
 
3526: Proximal and distal colon tumors as distinct biologic entities with different prognoses.
Missiaglia E., Jacobs B., Di Narzo AF, Soneson C., Roth A., Bosman F., D'Ario G., Klingbiel D., Yan P., Delorenzi M. et al., 2013. p. 3526 dans Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Journal of Clinical Oncology. Peer-reviewed.
[WoS][serval:BIB_74F86B683886]
 
3577: Thymidylate synthase (TS) expression as a prognostic molecular marker in stage II/III colon cancer.
Klingbiel D., Missiaglia E., Yan P., Tejpar S., Roth A., D'Ario G., Delorenzi M., Bosman F., 2013. p. 3577 dans Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Journal of Clinical Oncology. Peer-reviewed.
[WoS][serval:BIB_FBAEACB696F1]
 
e14544: Connecting gene expression subtypes of colorectal cancer (CRC) with cell lines and drug resistance
Budinska E., Wilding J., Popovici VC, Missiaglia E., Roth A., Bosman F., Delorenzi M., Bodmer W., Tejpar S., 2013. pp. e14544 dans Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Journal of Clinical Oncology. Peer-reviewed.
[WoS][serval:BIB_9300DECC71BC]
 
HES6 enhances the motility of alveolar rhabdomyosarcoma cells.
Wickramasinghe CM, Domaschenz R, Amagase Y, Williamson D, Missiaglia E, Shipley J, Murai K, Jones PH, 2013/01. Experimental Cell Research, 319 (1) pp. 103-112. Peer-reviewed.
[DOI][Pmid][serval:BIB_5086C7F6030E]
2012
 
Reply to S. Stegmaier et al
Missiaglia Edoardo, Williamson Dan, Chisholm Julia, Wirapati Pratyaksha, Pierron Gaëlle, Petel Fabien, Concordet Jean-Paul, Thway Khin, Oberlin Odile, Pritchard-Jones Kathy et al., 2012/11/10. Journal of Clinical Oncology, 30 (32) pp. 4040-4041.
[DOI][WoS][serval:BIB_FD1D68C62ED4]
 
Mpn1, mutated in poikiloderma with neutropenia protein 1, is a conserved 3'-to-5' RNA exonuclease processing U6 small nuclear RNA.
Shchepachev V., Wischnewski H., Missiaglia E., Soneson C., Azzalin C.M., 2012/10/25. Cell reports, 2 (4) pp. 855-865. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_56A1BBA27628]
 
Inconvenience of Convenience Cohorts: Rhabdomyosarcoma and the PAX-FOXO1 Biomarker. Rosenberg et al – Letter to Editor
Williamson D, Missiaglia E, Chisholm J, Shipley J, 2012/08. Cancer Epidemiology, Biomarkers & Prevention, 8 p. 1388. Peer-reviewed.
[DOI][Pmid][serval:BIB_39CD85B5E3F6]
 
Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.
Tonelli R., McIntyre A., Camerin C., Walters Z.S., Di Leo K., Selfe J., Purgato S., Missiaglia E., Tortori A., Renshaw J. et al., 2012/02/01. Clinical cancer research, 18 (3) pp. 796-807. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3A83CD7D142B]
 
MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells.
Carrascosa C., Obula R.G., Missiaglia E., Lehr H.A., Delorenzi M., Frattini M., Rüegg C., Mariotti A., 2012. Oncogene, 31 (12) pp. 1521-1532. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9292FDA822C8]
 
PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
Missiaglia E., Williamson D., Chisholm J., Wirapati P., Pierron G., Petel F., Concordet J.P., Thway K., Oberlin O., Pritchard-Jones K. et al., 2012. Journal of Clinical Oncology, 30 (14) pp. 1670-1677. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FF3A89135856]
2011
 
Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I non-seminomatous testicular germ-cell tumours.
Gilbert D.C., Chandler I., Summersgill B., McIntyre A., Missiaglia E., Goddard N.C., Huddart R.A., Shipley J., 2011/08. International journal of andrology, 34 (4 Pt 2) pp. e114-21; discussion e121. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D618D01B06EA]
 
Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas.
Thway K., Selfe J., Missiaglia E., Fisher C., Shipley J., 2011/07. Journal of clinical pathology, 64 (7) pp. 587-591. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F0532610DDE8]
 
Minimum regions of genomic imbalance in stage I testicular embryonal carcinoma and association of 22q loss with relapse.
Gilbert D.C., McIntyre A., Summersgill B., Missiaglia E., Goddard N.C., Chandler I., Huddart R.A., Shipley J., 2011/03. Genes, chromosomes & cancer, 50 (3) pp. 186-195. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_11B0168DABCC]
 
Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives.
Martins A.S., Olmos D., Missiaglia E., Shipley J., 2011. Sarcoma, 2011 p. 209736. Peer-reviewed.
[DOI][Pmid][serval:BIB_F22B254E0B89]
2010
 
Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
Zibat A., Missiaglia E., Rosenberger A., Pritchard-Jones K., Shipley J., Hahn H., Fulda S., 2010/12/02. Oncogene, 29 (48) pp. 6323-6330. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1107BBCA2262]
 
Reply to J.R. Anderson et al
Williamson Daniel, Missiaglia Edoardo, de Reyniès Aurélien, Pierron Gaëlle, Thuille Benedicte, Palenzuela Gilles, Thway Khin, Orbach Daniel, Laé Marick, Fréneaux Paul et al., 2010/10/10. Journal of Clinical Oncology, 28 (29) pp. e589-e590. Peer-reviewed.
[DOI][WoS][serval:BIB_440F6BFB4ACB]
 
Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells.
Rao P.K., Missiaglia E., Shields L., Hyde G., Yuan B., Shepherd C.J., Shipley J., Lodish H.F., 2010/09. FASEB journal, 24 (9) pp. 3427-3437. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EC5B079B8EFD]
 
MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas.
Missiaglia E., Shepherd C.J., Patel S., Thway K., Pierron G., Pritchard-Jones K., Renard M., Sciot R., Rao P., Oberlin O. et al., 2010/06/08. British journal of cancer, 102 (12) pp. 1769-1777. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_87CE2603B824]
 
Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
Williamson D., Missiaglia E., de Reyniès A., Pierron G., Thuille B., Palenzuela G., Thway K., Orbach D., Laé M., Fréneaux P. et al., 2010/05/01. Journal of clinical oncology, 28 (13) pp. 2151-2158. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4CDA4191F564]
 
Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.
Missiaglia E., Dalai I., Barbi S., Beghelli S., Falconi M., della Peruta M., Piemonti L., Capurso G., Di Florio A., delle Fave G. et al., 2010/01/10. Journal of clinical oncology, 28 (2) pp. 245-255. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_10593F772223]
2009
 
Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Missiaglia E., Selfe J., Hamdi M., Williamson D., Schaaf G., Fang C., Koster J., Summersgill B., Messahel B., Versteeg R. et al., 2009/06. Genes, chromosomes & cancer, 48 (6) pp. 455-467. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_51FF66B07994]
2007
 
Genomic copy number and expression patterns in testicular germ cell tumours.
McIntyre A., Summersgill B., Lu Y.J., Missiaglia E., Kitazawa S., Oosterhuis J.W., Looijenga L.H., Shipley J., 2007/12/17. British journal of cancer, 97 (12) pp. 1707-1712. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8CB7575DB339]
 
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors.
Dalai I., Missiaglia E., Barbi S., Butturini G., Doglioni C., Falconi M., Scarpa A., 2007/03. Neoplasia, 9 (3) pp. 181-183. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_655BC8F27C7C]
2006
 
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
Butturini G., Bettini R., Missiaglia E., Mantovani W., Dalai I., Capelli P., Ferdeghini M., Pederzoli P., Scarpa A., Falconi M., 2006/12. Endocrine-related cancer, 13 (4) pp. 1213-1221. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4140186007B]
 
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.
Roldo C., Missiaglia E., Hagan J.P., Falconi M., Capelli P., Bersani S., Calin G.A., Volinia S., Liu C.G., Scarpa A. et al., 2006/10/10. Journal of clinical oncology, 24 (29) pp. 4677-4684. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CEDD1237C5B2]
2005
 
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway.
Missiaglia E., Donadelli M., Palmieri M., Crnogorac-Jurcevic T., Scarpa A., Lemoine N.R., 2005/01/06. Oncogene, 24 (1) pp. 199-211. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C908ED41AF0D]
2004
 
Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis.
Missiaglia E., Blaveri E., Terris B., Wang Y.H., Costello E., Neoptolemos J.P., Crnogorac-Jurcevic T., Lemoine N.R., 2004/10/20. International journal of cancer, 112 (1) pp. 100-112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4FA1E795697D]
 
Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11.
Moore P.S., Missiaglia E., Beghelli S., Bragantini E., Mina M.M., Zamboni G., Falconi M., Scarpa A., 2004/06. Journal of cancer research and clinical oncology, 130 (6) pp. 339-345. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B33D2713C503]
2003
 
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine.
Cecconi D., Astner H., Donadelli M., Palmieri M., Missiaglia E., Hamdan M., Scarpa A., Righetti P.G., 2003/12. Electrophoresis, 24 (24) pp. 4291-4303. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_200EB230D327]
 
Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
Crnogorac-Jurcevic T., Missiaglia E., Blaveri E., Gangeswaran R., Jones M., Terris B., Costello E., Neoptolemos J.P., Lemoine N.R., 2003/09. The Journal of pathology, 201 (1) pp. 63-74. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B830BFAAA933]
2002
 
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M., Gisslinger H., Tosetto A., Rintelen C., Mannhalter C., Pabinger I., Heis N., Castaman G., Missiaglia E., Lechner K. et al., 2002/09. American journal of hematology, 71 (1) pp. 1-6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DDC03267B6A8]
 
Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas.
Terris B., Blaveri E., Crnogorac-Jurcevic T., Jones M., Missiaglia E., Ruszniewski P., Sauvanet A., Lemoine N.R., 2002/05. The American journal of pathology, 160 (5) pp. 1745-1754. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2495E993C3F5]
 
Prime-boost vaccines encoding an intracellular idiotype/GM-CSF fusion protein induce protective cell-mediated immunity in murine pre-B cell leukemia.
Pasquini S., Peralta S., Missiaglia E., Carta L., Lemoine N.R., 2002/04. Gene therapy, 9 (8) pp. 503-510. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9EE346A2A940]
 
Sex chromosome anomalies in pancreatic endocrine tumors.
Missiaglia E., Moore P.S., Williamson J., Lemoine N.R., Falconi M., Zamboni G., Scarpa A., 2002/04/01. International journal of cancer, 98 (4) pp. 532-538. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8AC78611AA4A]
2001
 
Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL.
Moore P.S., Missiaglia E., Antonello D., Zamò A., Zamboni G., Corleto V., Falconi M., Scarpa A., 2001/10. Genes, chromosomes & cancer, 32 (2) pp. 177-181. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C06137FAA97]
 
High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.
Rigaud G., Missiaglia E., Moore P.S., Zamboni G., Falconi M., Talamini G., Pesci A., Baron A., Lissandrini D., Rindi G. et al., 2001/01/01. Cancer research, 61 (1) pp. 285-292. Peer-reviewed.
[WoS][Pmid][serval:BIB_087DBBD375FA]
2000
 
An additional unique candidate mutation (G2470A; M740I) in the original families with von Willebrand disease type 2 M Vicenza and the G3864A (R1205H) mutation.
Castaman G., Missiaglia E., Federici A.B., Schneppenheim R., Rodeghiero F., 2000/08. Thrombosis and haemostasis, 84 (2) pp. 350-351. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F95C01941BD2]
 
Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect.
Castaman G., Eikenboom J.C., Missiaglia E., Rodeghiero F., 2000/03. British journal of haematology, 108 (4) pp. 876-879. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_93C73E0D4604]
1999
 
The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
Tosetto A., Missiaglia E., Frezzato M., Rodeghiero F., 1999/11. Thrombosis and haemostasis, 82 (5) pp. 1395-1398. Peer-reviewed.
[WoS][Pmid][serval:BIB_DDB9D08A56C9]
1998
 
Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation.
Tosetto A., Rodeghiero F., Martinelli I., De Stefano V., Missiaglia E., Chiusolo P., Mannucci P.M., 1998/12. British journal of haematology, 103 (3) pp. 871-876. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E5EA075BE0E3]
1997
 
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V.
Castaman G., Lunghi B., Missiaglia E., Bernardi F., Rodeghiero F., 1997/11. British journal of haematology, 99 (2) pp. 257-261. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D44518DBC152]
 
The VITA project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Vicenza Thrombophilia and Atherosclerosis.
Tosetto A., Missiaglia E., Gatto E., Rodeghiero F., 1997/08. Thrombosis and haemostasis, 78 (2) pp. 859-863. Peer-reviewed.
[WoS][Pmid][serval:BIB_4D09B307B176]
 
The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism.
Tosetto A., Missiaglia E., Frezzato M., Rodeghiero F., 1997/06. British journal of haematology, 97 (4) pp. 804-806. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9978559CDF5D]
1996
 
Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V Leiden.
Castaman G., Ruggeri M., Tosetto A., Missiaglia E., Rodeghiero F., 1996/08. Thrombosis and haemostasis, 76 (2) p. 275. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6101B4C29C10]
 
Age-related reproductive success in solitarily and communally nesting female dormice (Glis glis).
Pilastro A., Missiaglia E., Marin G., 1996/07. Journal of Zoology, 239 (3) pp. 601-608. Peer-reviewed.
[DOI][WoS][serval:BIB_715C430661D2]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University